Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent

Table 3

Genotype distribution of control group (no-restenosis + focal restenosis) versus diffuse restenosis group; G/G versus G/C + C/C and A/A versus A/C + C/C, chi-square.

Polymorphism	Genotype	Control group (%)	Diffuse restenosis group (%)
rs2010963	Normal (G/G carriers)	41 (41%)	58 (55.2%)	0.041
	Variant (G/C + C/C carriers)	59 (59%)	47 (44.8%)
rs699947	Normal (A/A carriers)	21 (21%)	28 (26.7%)	0.342
	Variant (A/C + C/C carriers)	79 (79%)	77 (73.7%)